Hela Romdhani

Education

Ph.D., mathematics and statistics, Laval University; M.S., information processing, National Engineering School of Tunis; B.S., statistics and data analysis, Higher School of Statistics and Data Analysis; Diploma, mathematics and computer sciences, Higher School Preparatory Classes

Summary of Experience

Dr. Romdhani specializes in the application of advanced statistical methods to address a wide array of research questions in health care, including in the area of health economics and outcomes research (HEOR). She has broad quantitative research experience conducting studies to assess the economic burden of various illnesses, treatment patterns, and drug safety and efficacy profiles in a range of therapeutic areas, including oncology, gastroenterology, immunology, neurology, cardiology, infectious diseases, and rare and hereditary diseases. Dr. Romdhani’s expertise includes conducting real-world evidence (RWE) studies, retrospective database analyses, chart review studies, and systematic and targeted literature reviews. Her research has been published in peer-reviewed journals and presented at clinical and economic research conferences.

• Real-World Experience of Pediatric Patients Treated with Peanut (Arachis Hypogaea) Allergen Powder-Dnfp

  Annals of Allergy, Asthma & Immunology, 2023
  2023

  Portnoy J, Shroba J, Tilles S, Romdhani H, Donelson SM, Latremouille-Viau D, Bungay R, Chen K, McCann W

  HEOR, Epidemiology & Market Access
• Treatment and Comorbidity Burden among People Living with HIV: A Review of Systematic Literature Reviews

  Journal of Drug Assessment, 2022
  2022

  Taiwo BO, Romdhani H, Lafeuille MH, Bhojwani R, Milbers K, Donga P

  HEOR, Epidemiology & Market Access
• Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study

  Drugs - Real World Outcomes, 2021
  2021

  Gordan L, Chang M, Lafeuille MH, Romdhani H, Paramasivam F, Maiese EM, McKay C

  HEOR, Epidemiology & Market Access
• Disease Management and Outcomes in Patients Hospitalized for Acute Heart Failure in Japan

  Cardiology and Therapy, 2021
  2021

  Chen L, Ionescu-Ittu R, Romdhani H, Guérin A, Kessler P, Borentain M, Friend K, DeSouza M, Sato N

  HEOR, Epidemiology & Market Access
• Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States

  The Journal of Urology, 2021
  2021

  Ryan CJ, Ke X, Lafeuille MH, Romdhani H, Kinkead F, Lefebvre P, Petrilla A, Pulungan Z, Kim S, D'Andrea DM, Francis P, Freedland SJ

  HEOR, Epidemiology & Market Access
• Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data

  Current Medical Research and Opinion, 2021
  2021

  Freedland SJ, Ke X, Lafeuille MH, Romdhani H, Kinkead F, Lefebvre P, Petrilla A, Pulungan Z, Kim S, D'Andrea DM, Francis P, Ryan CJ

  HEOR, Epidemiology & Market Access
• Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate

  PharmacoEconomics - Open, 2019
  2019

  Emond B, Joshi K, El Khoury AC, Lafeuille MH, Pilon D, Tandon N, Romdhani H, Lefebvre P

  HEOR, Epidemiology & Market Access
• Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy

  Clinical Lymphoma, Myeloma & Leukemia, 2019
  2019

  Emond B, Sundaram M, Romdhani H, Lefebvre P, Wang S, Mato A

  HEOR, Epidemiology & Market Access
• Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus

  Journal of Managed Care & Specialty Pharmacy, 2019
  2019

  Benson C, Emond B, Romdhani H, Lefebvre P, Côté-Sergent A, Shohoudi A, Tandon N, Chow W, Dunn K

  HEOR, Epidemiology & Market Access
• Economic burden of treatment failure in chronic lymphocytic leukemia patients

  Current Medical Research and Opinion. 2018 Jun;34(6):1135-1142
  2018

  Wang S, Lafeuille MH, Lefebvre P, Romdhani H, Emond B, Senbetta M

• Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV

  Journal of Managed Care & Specialty Pharmacy. 2018 Oct;24(10):1040-1051
  2018

  Dunn K, Lafeuille MH, Jiao X, Romdhani H, Emond B, Woodruff K, Pesa J, Tandon N, Lefebvre P

  HEOR, Epidemiology & Market Access
• Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast Cancer

  Advances in Therapy. 2018 Aug;35(8):1251-1264
  2018

  Guérin A, Goldschmidt D, Small T, Gagnon-Sanschagrin P, Romdhani H, Gauthier G, Kelkar S, Wu EQ, Niravath P, Dalal AA

  HEOR, Epidemiology & Market Access
• Current Treatment Patterns Among Postmenopausal Women with HR+/HER2- Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study

  Advances in Therapy. 26 Mar 2018:1-12
  2018

  Goldschmidt D, Dalal AA, Romdhani H, Kelkar S, Guerin A, Gauthier G, Wu EQ, Niravath P, Small T

  HEOR, Epidemiology & Market Access

• October 23, 2023

  HEOR and Epidemiology Research from Analysis Group Featured at AMCP Nexus Meeting

  HEOR, Epidemiology & Market Access